ScripMylan NV has a long history in the generic pharmaceutical market, maintaining its independence while plenty of other mid-sized specialty generic peers were absorbed into larger corporations. Now the
Generics BulletinThe challenging US pricing environment for generic drugs appears poised to continue through 2017, presenting a long-lasting headache for manufacturers, which rely on the enormous US market to drive gr
ScripEton Pharmaceuticals Inc. has appointed Sean Brynjelsen CEO. Brynjelsen brings more than 20 years of experience in the industry to the company and previously worked at pharma companies, including
ScripThe challenging US pricing environment for generic drugs appears poised to continue through 2017, presenting a long-lasting headache for manufacturers, which rely on the enormous US market to drive gr